Home/Biofrontera/Prof. Hermann Luebbert, PhD

PH

Prof. Hermann Luebbert, PhD

CEO & Chairman

Therapeutic Areas

Biofrontera Pipeline

Drug	Indication	Phase
BF-200 ALA (Ameluz®)	Actinic Keratosis - Pharmacokinetics	N/A (Post-Approval)

Leadership Team at Biofrontera

Chief Financial Officer

Chief Commercial Officer

Samantha Widdicombe

Senior Vice President of Sales & Marketing

Jon Lyons, PhD, MBA

Vice President of Scientific & Medical Affairs

View full Biofrontera profile